Translational Development Acquisition Corp. (TDACW)
NASDAQ
Closed
Sep 4, 2026
Day's Range
1.8552 wk Range
0.1700Overview - TDACW - Translational Development Acquisition Corp.
Key Statistics
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-0.49%‬
Return on Equity
‪3.63%‬
Ownership
Shares Outstanding
21.90M
Float
15.04M
Market Cap - TDACW - Translational Development Acquisition Corp.
Peers - TDACW - Translational Development Acquisition Corp.
Peer Comparison
Compared with companies in Shell Companies listed on NASDAQ.
- TDACWNASDAQTranslational Development Acquisition Corp.34.83MMarket Cap+85.55%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- SLVRNASDAQSprott Silver Miners & Physical Silver ETF1.58BMarket Cap+41.73%52-week change27.26P/E (Trailing)—Profit Margin
- AVRNASDAQAnteris Technologies Ltd.851.78MMarket Cap+54.01%52-week change-3.43P/E (Trailing)‪70.25%‬Profit Margin
- CCXINASDAQChemoCentryx Inc746.38MMarket Cap+23.43%52-week change-7.09P/E (Trailing)‪99.05%‬Profit Margin
- DMDMIINASDAQDrugs Made In America Acquisition II Corp.647.82MMarket Cap+2.85%52-week change35.07P/E (Trailing)‪0.00%‬Profit Margin
- CECEPFNASDAQCantor Equity Partners IV, Inc. Class A Ordinary Shares594.36MMarket Cap+2.69%52-week change28.11P/E (Trailing)‪0.00%‬Profit Margin
- DBCANASDAQD. Boral Acquisition I Corp.557.59MMarket Cap+1.79%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - TDACW - Translational Development Acquisition Corp.
About
Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC), dedicated to facilitating mergers, acquisitions, or similar business combinations with one or more entities. As a SPAC, its primary function is to raise capital through an initial public offering (IPO) with the intention of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
